Skip to content

Comparison of continuous veno-venous hemofiltration and continuous veno-venous hemodiafiltration on solute clearance efficiency and filter life in critically ill patients

Comparison of continuous veno-venous hemofiltration and continuous veno-venous hemodiafiltration on solute clearance efficiency and filter life in critically ill patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070941
Enrollment
Unknown
Registered
2023-04-26
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury

Interventions

Group A:Patients in the group A firstly received CVVH treatment followed by CVVHDF
Group B:Patients in group B firstly received CVVHDF treatment followed by CVVH

Sponsors

Kunshan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1: Over 18 years old 2: AKI diagnosed based on the KDIGO clinical practice guidelines for acute kidney injury, 2012 3: AKI patients with indicators that initiated CRRT, i.e., (a) stage 2 of AKI; (b) AKI patients combined with acute hypervolemic heart failure, acute pulmonary edema, hemodynamic instability due to septic shock, severe acid-base and electrolyte disorders, multiple organ dysfunction that necessitated CRRT.

Exclusion criteria

Exclusion criteria: 1: Patients with chronic renal failure or end-stage renal disease receiving maintenance dialysis 2: Patients treated with CRRT for non-renal reasons such as poisoning without complications of AKI 3: The required treatment parameters could not be used because of the disease condition 4: During the treatment process, the treatment mode and parameters needed to be changed according to the disease condition 5: The crossover remained unfinished because of the withdrawal or death

Design outcomes

Primary

MeasureTime frame
Delivered dose;Equipment pressure indicators;Filter life;

Countries

China

Contacts

Public ContactCheng Hang

Kunshan Hospital of Traditional Chinese Medicine

hangcheng@njucm.edu.cn+86 17715516820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026